3.0
24. März 2021
Aktueller Mitarbeiter, mehr als 3 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great product, great people, fast paced, challenging.
Kontras
With growth has come micromanaging and pharma culture which is why I am concerned about the direction we are going. Dexcom is becoming everything I hated and left years ago. Time will tell. Ashame if they ruin a good thing.